Participative research for individualised care in cardiovascular diseases (PRIC-CVD): study protocol for a

Bianca Steiner1,2, Marlo Verket3, Karolien Baldewijns4

  • 1German Foundation for the Chronically Ill, Berlin, Germany bi.steiner@ostfalia.de.

BMJ Open
|July 4, 2025
PubMed

Insights

This study establishes patient panels across Europe to gather insights for personalized cardiovascular disease (CVD) care. Patient input will improve diagnosis, treatment, and self-care strategies for better health outcomes.

Area of Science:

  • Cardiovascular Health
  • Patient-Centered Care
  • Public Health Research

Background:

  • Cardiovascular disease (CVD) poses a significant public health challenge.
  • Existing interventions need enhancement through individualized care approaches.
  • The iCARE4CVD project aims to personalize CVD prevention and treatment.

Purpose of the Study:

  • To integrate patient perspectives into the iCARE4CVD project.
  • To identify patient preferences and needs for improved CVD diagnosis, treatment, and self-care.
  • To establish representative patient panels for ongoing project contribution.

Main Methods:

  • A multicentre, mixed-methods study involving patient panels in four European countries.
  • Inclusion of 40-48 patients across the CVD spectrum over 3.5 years.
  • Patient panel tasks include identifying Patient-Reported Outcome and Experiences Measures, developing motivational models, providing feedback on care processes, and usability testing of digital tools.

Main Results:

  • Patient panels will provide continuous input into the iCARE4CVD project.
  • Identification of meaningful Patient-Reported Outcome and Experiences Measures.
  • Development of patient-centered strategies for adherence and care processes.

Conclusions:

  • Incorporating patient insights is crucial for effective personalized cardiovascular care.
  • The study will generate actionable data to enhance CVD prevention and management.
  • Findings will inform the development of patient-centered digital health tools.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
38
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
428
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
38
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
472
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
180